Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study

BACKGROUND: The recombinant vesicular stomatitis virus (rVSV) vaccine expressing the Zaire Ebola virus (ZEBOV) glycoprotein is efficacious in the weeks following single-dose injection, but duration of immunity is unknown. We aimed to assess antibody persistence at 1 and 2 years in volunteers who rec...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Lancet Infect Dis
Hoofdauteurs: Huttner, Angela, Agnandji, Selidji Todagbe, Combescure, Christophe, Fernandes, José F, Bache, Emmanuel Bache, Kabwende, Lumeka, Ndungu, Francis Maina, Brosnahan, Jessica, Monath, Thomas P, Lemaître, Barbara, Grillet, Stéphane, Botto, Miriam, Engler, Olivier, Portmann, Jasmine, Siegrist, Denise, Bejon, Philip, Silvera, Peter, Kremsner, Peter, Siegrist, Claire-Anne
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2018
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6408946/
https://ncbi.nlm.nih.gov/pubmed/29627147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(18)30165-8
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items